Home › NGM And Merck Announce Broad Strategic Collaboration To Discover, Develop And Commercialize Novel Biologic Therapeutics
 

Keywords :   


NGM And Merck Announce Broad Strategic Collaboration To Discover, Develop And Commercialize Novel Biologic Therapeutics

2015-03-04 04:25:06| drugdiscoveryonline News Articles

NGM Biopharmaceuticals, Inc., a privately-held biotechnology company and Merck, known as MSD outside the United States and Canada, recently announced they have entered into a multi-year collaboration to research, discover, develop and commercialize novel biologic therapies across a wide range of therapeutic areas

Tags: develop broad discover collaboration

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
19.05Gillette Venus Announces Ambassadors Ahead of the Olympic and Paralympic Games Paris 2024
19.05Eastern North Pacific Tropical Weather Outlook
More »